The diseases that afflict humans and other animals have marked differences, however, the similarities between these maladies are numerous. In fact, the seemingly separate fields of veterinary and human medicine are more similar than unique, so focusing on how basic biological studies can inform both medical fields to ensure human and animal health. Comparative medicine forms a bridge between these disciplines, exploring disease processes in animals and in humans with an effort to improve medicine for each. Biomedical research always has depended on animal research to advance. Techniques ranging from blood transfusion to kidney dialysis to hip and heart valve replacement surgeries to deep brain stimulation were developed initially in animal models and are now used in both hospitals and veterinary clinics around the world. In this issue of the *Yale Journal of Biology and Medicine* (*YJBM*), we aim to give our readers a better understanding of laboratory animal models and their critical role in biomedical research, as well as the role of natural models of human diseases in non-laboratory animals. 

Biomedical research comprises of diverse research styles, from basic research, which aims to define fundamental scientific principles by observation of phenomena, to clinical research, testing novel treatments in patients. In between, however, lies an important interdisciplinary field that aims to translate basic scientific findings from the laboratory setting to potential treatments for disease. In basic research, complex systems are broken down into their components to understand essential principles of biology. The hypotheses driven from basic biological findings are brought to bear in complex multicellular organisms, to be found either limited to simple systems due simply to the sheer complexity an entire organism brings with it, or to be found more universal. As Macy & Horvath describe in their perspective, comparative medicine acts to "better understand the mechanism of human and animal disease" through exactly this scheme. Translational medicine takes basic research discoveries made in increasingly complex species and develops them into clinical applications. Throughout the translation process and beyond into more clinical research aspects, the application of comparative medicine concepts is "critical for success." 

The range of comparative medicine is extensive due to the applicability of most biomedical fields to both human and animal health research. As Macy & Horvath state, comparative medicine is not a "particular discipline," instead, it's an "investigative mindset that seeks to reveal common threads that weave different pathophysiologic processes into translatable approaches and outcomes using various models." Throughout this issue of YJBM, manuscripts will discuss the application of comparative medicine to a variety of fields. 

On the basic research end, Lawson *et al* describe how extracellular vesicles (EV) can be used as non-invasive markers of diseases in both humans and animals. EV are cellularly derived pods with a phospholipid bilayer containing a variety of organic materials, such as nucleic acids, proteins, or lipids. Their cargo is highly regulated, allowing for cellular communication throughout the body. During early stages of diseases, the contents of EV change, allowing them to be a marker for diseases at earlier stages than other diagnostic tests. Additionally, EV may be particularly useful in veterinary sciences, as species-specific diagnostic tools are often not available, whereas disease-marking modulations in EV contents may be analogous between species, allowing for the development of general diagnostic tools to be used across species. 

Moving beyond cellular biology, the application of comparative medicine to physiology has also proven insightful. In a review of estrogen production, Raeside describes the human and equine research behind establishing the fetal-placental unit as an estrogen producer. Studying steroids is difficult, as their role in physiology is greatly varied between species, and as such, outside of primate species, animal models for steroid physiology are difficult to find. However, the overlapping features of steroid hormone production in human and equine pregnancies allowed for the horse to be central in discovery and evaluating steroid hormones. As Raeside describes, currently, the equine model and the discoveries scientists have made from it are being applied to advance estrogen replacement therapy. 

As applicable as comparative medicine is in cellular biology, as demonstrated by Lawson *et al*and Raeside, it is also applicable in psychology. Bales *et al* describe two important animal models of the neurobiology of pair bonding, the close relationship formed between two adults. Prairie voles have been the predominant animal model of pair bonding, as they are socially monogamous rodents both in the wild and in the laboratory. Titi monkeys are a novel model of pair bonding. These New World monkeys, both in captivity at the California National Primate Research Center and in the wild, are composed of monogamous parent pairs and offspring. In addition, the neurobiology of titi monkeys is much closer to that of humans than prairie voles, allowing for them to be a strong model for pair bonding in humans, not just at a behavioral level, but also in the neuromolecular dynamics of pair bond formation. Both prairie voles and titi monkeys have allowed for a greater understanding of the neurobiological mechanisms of social bonds in animals and humans; of note, visual mating stimuli and dopaminergic reward systems have been identified in titi monkeys to play a critical role in pair bond formation. 

Bales *et al* and Lawson *et al* highlight the breadth of comparative medicine. One of the most commonly used tools used in comparative medicine is the laboratory mouse. Laboratory mice are a variety of inbred strains of mice that are used to model human diseases in a reductionistic setting where there is little inter-individual genetic variation and all environmental conditions can be controlled. This allows scientists to measure, for example, the impact of a single gene at a time to understand its contributions to a disease, to form hypotheses for the development of preventative, therapeutic, and curative treatments. Murine cancer models have greatly advanced the knowledge of how cancer cells reestablish the landscape of the tissue in which the tumor is growing. Habenicht *et al* explore the biological changes tumor draining lymph nodes (TDLNs) undergo during oncogenesis in murine models. TDLNs lie downstream of tumors, such that tumor antigens drain into them. These lymph nodes are unique in that the oncogenic antigens are presented, yet immune responses are not launched against the tumor. Studies of murine TDLNs have revealed a variety of different mechanisms by which these lymph nodes are immunosuppressive in comparison to lymph nodes not downstream of tumors. Habenicht *et al* explain that although human TDLNs are unique in some aspects from those found in murine models, they have been identified in a variety of solid tumor (including melanoma, breast, oral, and rectal cancers) and non-solid tumors (non-Hodgkin's lymphoma) and have many similar properties to murine TDLNs, including their pathology, emphasizing the importance these models have played in understanding the fundamental processes that occur during oncogenesis. 

There are many different strains of inbred laboratory mice that each have unique genetics, characteristics, and phenotypes under a variety of different experimental conditions, which makes certain strains particularly optimal for particular studies. For example, Samet & Tompkins explore the varied responses various murine strains have towards influenza infections. Although influenza is not naturally a murine pathogen, mice range from being highly susceptible to infection (such as the DBA/2 line) to resistant (C57/BL6 and BALB/c). These discrepancies have been predominantly attributed to the distinct immune responses that each mouse strain launches, modeling the diverse immune responses that humans also launch in response to viral infections. As Samet & Tompkins describe, the importance of studying different strains of mice lies in understanding how different host genetics contribute to immune responses, allowing us to identify mechanisms that lead to increased disease severity in humans, as well as what mechanisms influence the differences in responses to anti-viral vaccines and drugs. 

One limitation to using inbred laboratory mice is that they are bred and raised in sterile conditions which does not accurately model the real-world immune system challenge from the billions of bacteria and other microorganisms with which humans constantly come into contact. The microbiome of bacteria living on the skin and in the digestive system is increasingly appreciated as a major contributor to physiology and health. Ericsson *et al* describe their efforts comparing wild-caught mice to inbred laboratory mice in terms of the diversity of their microbiome. The wild-caught mice and those purchased from pet stores had greater microbiome diversity, and also a greater pathogen load than the sterile, traditional mice. As the mice from the real-world were bred in sterile conditions, the microbiome diversity of the offspring decreased. Ericsson *et al* share their insight into how to increase translatability of studies from sterile laboratory mice to humans through suitable modeling of microbiome diversity. 

Another important consideration of comparative medicine is whether a disease occurs spontaneously in other species, or whether certain disease processes can be induced in a model system. Olivry *et al* review the variety of spontaneous and induced models of atopic dermatitis, also known as eczema. While induced models of skin lesions have face validity for the disease process in humans, they have had limited translational efficacy for moving new effective treatments into the clinic. Spontaneous skin lesions are observed in mice with genetic mutations, as well as in dogs. These spontaneous skin lesions may have better translational efficacy if the cause of the disease is similar across species. Olivry *et al* argue that transcriptomic data from humans before and after successful treatment should be used to constrain the various models of atopic dermatitis to have maximal impact on finding new effective treatments for eczema. 

Spontaneous disease models in veterinary medicine are a chief component of comparative medicine where newly developed therapies can be deployed in both veterinary and human medicine. Ngheim *et al* describe spontaneous muscular dystrophy in golden retriever dogs and how the variability in disease progression across individual dogs compares to the human disease. They hypothesize that metabolic changes in muscles contribute to some dogs degenerating more rapidly compared to others with the disease, and that this mechanism can be targeted with novel therapies. Adin *et al* describe spontaneous diabetes in dogs, and how that compares to human Type 1 diabetes. Naturally-occurring diabetes in dogs provides the opportunity to test pancreatic islet transplantation as a means for curing diabetes, and Adin *et al* argue for future dual market commercialization of this technique into the veterinary and human clinical practice. 

In humans, many diseases are genetic-based in which single genes are mutated or deleted or large regions of chromosomes are multiplied or missing. The high levels of genetic similarities between mammalian species make it such that equivalent mutations occur in homologous genes in animals, similar diseases occur. Gurda *et al* describe canine and feline models of hereditary, genetic disorders that are orthologs of human diseases. The range of diseases is vast, from lysosomal storage diseases to muscular and immune system diseases, with parallel and divergent properties from humans. As Gurda *et al*state, for many genetic diseases, "there are no satisfactory therapies due to a lack of clinically relevant animal models that faithfully recapitulate human genetic disease," but the spontaneous, orthologous disorders in larger animals allow not only for the study of such disorders to aid in finding cures and therapies for human diseases, but also for the animal diseases themselves. Gurda *et al* emphasize the importance of partnerships between veterinarians, physicians, and researchers to allow for greater global knowledge of the basic biological causes and mechanisms of genetic diseases, as well as to provide a platform for the discovery of markers of disease (such as the EV contents as described by Lawson *et al*) and the drug development process, eventually leading to clinical therapies for genetic diseases. 

Animal models of disease are simply that---models. Each model will have distinct similarities and differences with the human disease. As such, the power of comparative medicine lies in the ability to understand the disease mechanisms in a spread of animal models to get a more global perception of the best way to approach human diseases. For example, in this issue, there are three manuscripts describing different animal models of cardiovascular diseases. Every year, heart disease is accountable for nearly one in four deaths in the United States, making it the leading cause of death in both men and women. Cardiovascular research aims not just to find therapies for those with heart diseases, but also to understand the molecular underpinnings of the early stages of disease to provide the public with better preventative therapeutics. Comparative medicine studies have enhanced our knowledge of cardiovascular health many times over. Borovac *et al* discuss how animal models have allowed for the development of biomedical and technological solutions to in-stent neoatherosclerosis and thrombosis after percutaneous coronary intervention. Porcine and rabbit models have been the most influential in this field, as their cardiovascular anatomy and physiology are highly similar to that of humans and it has been continuously proven that there is a high level of translatable value from these models to humans. Technologies developed in these models include pharmacotherapy to reduce inflammation, biodegradable polymer based bioresorbable vascular scaffolds and stents, and the delivery of biodegradable magnetic nanoparticles to guide healing endothelial cells to lesions to aid in the wound healing process. Without animal models, such technologies could not have been developed for use in treating humans. 

Preventing cardiovascular disease is an important goal for reducing mortality in the United States and worldwide. Estrogen has known protective effects against coronary artery hardening, yet using this information to reduce mortality is complicated. Kaplan & Manuck describe over three decades of research into cardiovascular risk mitigation in socially-housed female non-human primates (NHP). Social hierarchies in NHP share similar complexity to the social networks in humans not observed in other organisms such as laboratory mice. What Kaplan & Manuck demonstrate, is that the stress from low social rank can be enough to produce ovulation irregularity in pre-menopausal animals, which then leads to worse coronary artery outcomes. Importantly they demonstrate that treating the ovulation irregularity via oral contraceptives is sufficient to protect against coronary artery atherosclerosis in stressed monkeys. Ensuring healthy ovarian function in pre-menopausal women, despite social and other forms of stress, can perhaps mitigate coronary heart disease risk and reduce cardiovascular mortality in humans. 

Hypertrophic cardiomyopathy (HCM) is a condition in which the heart muscle is enlarged, leading to functional impairment, and is predominantly caused by mutations in troponin or myosin associated proteins and is fairly prevalent, occurring in about one in 500 people. In humans, HCM presents in a highly heterogeneous manner. Ueda & Stern describe the advantages and limitations of available models of HCM and reiterate what many of the manuscripts in this issue state---multiple models for the same disease allow for a more thorough understanding of the disease as a whole. Transgenic laboratory mouse models of HCM allow for the deep analysis of molecular interactions in cardiac tissues, particularly because mice are more readily genetically manipulatable. However, the differences in cardiac physiology compared to humans is a limitation. Spontaneous HCM models in felines and NHP have been shown to share remarkably similar genetic, physiological, and molecular features to human HCM. These natural large animal models have been greatly influential in our understanding of human HCM and allow for the development of novel therapeutics that would be difficult, if not impossible, to develop merely with the murine model. 

Comparative medicine seeks to optimally combine information from basic research, reductionistic animal models, and the observation and treatment of spontaneous diseases in animals to improve medical treatment. Each stream of information has caveats and limitations, and it is only through their combination that biomedical science can progress. Comparative medicine is not a field that can be easily condensed into one issue of *YJBM*, however, the thirteen articles in this issue cover a broad range of the applications of comparative medicine, highlighting the power of animal models in a variety of fields.
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